Skip to content

Mapping Mood in the Subthalamic Nucleus in Parkinson's Disease (PD)

Mapping Mood in the Subthalamic Nucleus in PD

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00847431
Acronym
MOOD-D
Enrollment
81
Registered
2009-02-19
Start date
2008-12-31
Completion date
2015-12-31
Last updated
2016-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression, Parkinson's Disease

Keywords

Subthalamic Nucleus, Deep Brain Stimulation, Depression, Anxiety, Parkinson's Disease

Brief summary

The goal of this study is to determine the vulnerability of mood-related neurocircuitry in Parkinson Disease (PD) using deep brain stimulation of the subthalamic nucleus (STN DBS).

Interventions

None listed

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
National Institute of Neurological Disorders and Stroke (NINDS)
CollaboratorNIH
Washington University School of Medicine
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

for STN-DBS subjects: * Age 40 or older * DBS STN Surgery in past 2 to 36 months * Ability to tolerate turning off Stimulators * Ability to read and comprehend questions * English speaking

Exclusion criteria

for STN-DBS subjects: * Other severe complications post surgery: stroke, seizure, major loss of consciousness, other brain trauma/surgery, or head injuries(i.e. near drowning), encephalitis, or hydrocephalus, blindness, deafness * Clinically determined Dementia ( Most recent MMSE score of \>24) Inclusion Criteria for Control subject: * Age 40 or older * Ability to read and comprehend questions * English speaking

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026